Concord Biotech Limited (BOM:543960)
India
· Delayed Price · Currency is INR 1,177.30
-29.00 (-2.40%)
At close: Mar 9, 2026
Concord Biotech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Market Capitalization | 122,955 | 175,818 | 159,100 | - | - | - | Upgrade
|
| Market Cap Growth | -30.55% | 10.51% | - | - | - | - | Upgrade
|
| Enterprise Value | 119,651 | 173,015 | 157,079 | - | - | - | Upgrade
|
| Last Close Price | 1177.30 | 1665.74 | 1503.90 | - | - | - | Upgrade
|
| PE Ratio | 39.35 | 47.31 | 51.64 | - | - | - | Upgrade
|
| PS Ratio | 10.61 | 14.65 | 15.65 | - | - | - | Upgrade
|
| PB Ratio | 6.73 | 9.70 | 10.42 | - | - | - | Upgrade
|
| P/TBV Ratio | 6.74 | 9.71 | 10.42 | - | - | - | Upgrade
|
| P/FCF Ratio | - | 131.85 | 88.50 | - | - | - | Upgrade
|
| P/OCF Ratio | - | 71.90 | 59.93 | - | - | - | Upgrade
|
| EV/Sales Ratio | 10.33 | 14.42 | 15.45 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 27.55 | 33.74 | 35.82 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 31.53 | 37.60 | 40.62 | - | - | - | Upgrade
|
| EV/FCF Ratio | - | 129.75 | 87.37 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.06 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.01 | 0.02 | 0.09 | 0.22 | 0.27 | Upgrade
|
| Debt / FCF Ratio | - | 0.02 | 0.05 | 0.31 | 1.19 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.18 | -0.18 | -0.11 | -0.09 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.76 | -0.65 | -0.62 | -0.39 | -0.36 | -0.34 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.49 | -1.51 | -1.38 | -1.88 | 2.99 | Upgrade
|
| Asset Turnover | - | 0.64 | 0.63 | 0.60 | 0.57 | 0.58 | Upgrade
|
| Inventory Turnover | - | 1.93 | 1.66 | 0.94 | 0.99 | 0.88 | Upgrade
|
| Quick Ratio | - | 4.77 | 4.58 | 2.43 | 2.71 | 3.92 | Upgrade
|
| Current Ratio | - | 6.17 | 6.31 | 3.79 | 4.08 | 5.74 | Upgrade
|
| Return on Equity (ROE) | - | 22.26% | 21.88% | 20.06% | 16.64% | 26.55% | Upgrade
|
| Return on Assets (ROA) | - | 15.40% | 15.04% | 13.26% | 11.47% | 17.80% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.97% | 25.28% | 24.02% | 20.75% | 17.83% | 30.10% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 24.90% | 24.80% | 22.70% | 19.80% | 28.10% | Upgrade
|
| Earnings Yield | 2.54% | 2.11% | 1.94% | - | - | - | Upgrade
|
| FCF Yield | - | 0.76% | 1.13% | - | - | - | Upgrade
|
| Dividend Yield | 0.91% | 0.64% | 0.58% | - | - | - | Upgrade
|
| Payout Ratio | - | 24.63% | 23.19% | 22.31% | 40.31% | 2.43% | Upgrade
|
| Total Shareholder Return | 0.27% | 0.64% | 0.58% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.